Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1981 1
1990 1
1991 1
1994 1
1995 1
2010 1
2012 1
2013 1
2015 2
2016 1
2019 1
2022 0
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
Observational study of adjuvant therapy with capecitabine in colon cancer.
Steffens CC, Tschechne B, Schardt C, Jacobs G, Valdix AR, Schmidt P, Hansen R, Kröning H, Wohlfarth T, Guggenberger D. Steffens CC, et al. Among authors: tschechne b. Curr Med Res Opin. 2015 Apr;31(4):731-41. doi: 10.1185/03007995.2015.1014030. Epub 2015 Feb 12. Curr Med Res Opin. 2015. PMID: 25651480
Capecitabine in the routine first-line treatment of elderly patients with advanced colorectal cancer--results from a non-interventional observation study.
Stein A, Quidde J, Schröder JK, Göhler T, Tschechne B, Valdix AR, Höffkes HG, Schirrmacher-Memmel S, Wohlfarth T, Hinke A, Engelen A, Arnold D. Stein A, et al. Among authors: tschechne b. BMC Cancer. 2016 Feb 10;16:82. doi: 10.1186/s12885-016-2113-8. BMC Cancer. 2016. PMID: 26865161 Free PMC article.
Low-dose recombinant interleukin-2 therapy in advanced multiple myeloma.
Peest D, Leo R, Bloche S, Hein R, Stannat-Kiessling S, Tschechne B, Fett W, Harms P, Hoffmann L, Bartl R, et al. Peest D, et al. Among authors: tschechne b. Br J Haematol. 1995 Feb;89(2):328-37. doi: 10.1111/j.1365-2141.1995.tb03308.x. Br J Haematol. 1995. PMID: 7873383 Clinical Trial.
12 results